Back to search
FDAFDA · Food and drugs·Recall number Z-0379-2016

LeMaitre Over-the-Wire Embolectomy Catheter 3F, 80cm, Model 1651-38. Indicated for the removal of arterial emboli and thrombi.

Published December 16, 2015 · Recall initiated: October 21, 2015

Summary

FDA records medical device Class II recall Z-0379-2016, published December 16, 2015 and initiated October 21, 2015. Recalling firm: LeMaitre Vascular, Inc.; Status: Terminated; Reported quantity: 4315 total; Lot: Lot Numbers: OTW3080 OTW3080® OTW3081® OTW3083® OTW3100®. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Manufacturing issue that could cause a pinhole in the formed end of the packaging, which may lead to compromised sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
LeMaitre Vascular, Inc.
Distributor
Worldwide Distribution. US nationwide including PUERTO RICO, and Australia, AUSTRIA, BELGIUM, COLOMBIA, COSTA RICA, Czech Republic, DENMARK, EGYPT, FRANCE, GERMANY, ICELAND, Italy, JAPAN, JORDAN, Latvia, LUXEMBOURG, MOROCCO, NETHERLANDS, Norway, Oman, PERU, PORTUGAL, Poland, Slovenia, Spain, Switzerland, Sweden, THAILAND, United Kingdom, United Arab Emirates, and VIETNAM.
Lot
Lot Numbers: OTW3080 OTW3080® OTW3081® OTW3083® OTW3100®
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LeMaitre Over-the-Wire Embolectomy Catheter 3F, 80cm, Model 1651-38. Indicated for the removal of arterial emboli and thrombi. recalled?

Yes. FDA published recall Z-0379-2016 on December 16, 2015. Reported hazard: Manufacturing issue that could cause a pinhole in the formed end of the packaging, which may lead to compromised sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter